VANNICA SOY: Open Payments
NPI 1245843473 · CYPRESS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,762 in 135 payments from 19 companies in 2025. Trend: 2023 $2,528 · 2024 $3,643 · 2025 $2,762
Food & beverage: $2,657Education: $105
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $399 |
| Novartis Pharmaceuticals Corporation | 19 | $380 |
| GENZYME CORPORATION | 6 | $264 |
| UCB, Inc. | 7 | $245 |
| Janssen Biotech, Inc. | 11 | $230 |
| PFIZER INC. | 10 | $189 |
| Galderma Laboratories, L.P. | 13 | $166 |
| Arcutis Biotherapeutics, Inc. | 8 | $150 |
| Incyte Corporation | 6 | $120 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
Products named: DUPIXENT, COSENTYX, SKYRIZI, Bimzelx, TREMFYA, CIBINQO, RINVOQ, Zoryve.
Industry payments across TX — which companies pay providers there.
